SLC7A11/xCT Rekombinanter Antikörper
SLC7A11/xCT Rekombinant Antikörper für IF/ICC, FC (Intra), Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
IF/ICC, FC (Intra), Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
230227C5
Kat-Nr. : 82115-2-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
82115-2-PBS bindet in IF/ICC, FC (Intra), Indirect ELISA SLC7A11/xCT und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | SLC7A11/xCT fusion protein Ag25431 |
| Vollständiger Name | solute carrier family 7, (cationic amino acid transporter, y+ system) member 11 |
| Berechnetes Molekulargewicht | 55 kDa |
| GenBank-Zugangsnummer | BC012087 |
| Gene symbol | SLC7A11 |
| Gene ID (NCBI) | 23657 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-A-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
SLC7A11 (also known as xCT) is a membrane transporter involved in the uptake of cystine. It promotes glutathione synthesis through the uptake of cystine and the concomitant release of glutamate. This, in turn, protects cells from oxidative stress, maintains cellular redox balance, and prevents cell death induced by lipid peroxidation. SLC7A11 has been identified as a potential target for cancer therapeutics. It is overexpressed in multiple malignant tumors and is closely associated with the growth, prognosis, metastasis, and treatment response of various cancers including lung cancer.







